NewsEvents

Your Yourlocation: Home > Therapeutic effect of inhaled tiotropium bromide(136310-93-5) powder and ipratropium bromide aerosol in the treatment of chronic obstructive pulmonary disease

The study of inhaled tiotropium bromide(136310-93-5) powder and ipratropium bromide quantitative aerosol treatment of chronic obstructive pulmonary disease observed, the study found that tiotropium bromide dry powder inhalation treatment of chronic obstructive pulmonary disease can play a better bronchial Expansion effect, and the patient's tolerance, and its safety is basically the same as ipratropium bromide, has a high application value. The article published on 2016 03 period "North Pharmaceutical".

The aim of this study was to observe the clinical efficacy of inhaled tiotropium bromide(136310-93-5) powder and ipratropium bromide aerosol in the treatment of chronic obstructive pulmonary disease.

We randomly selected 70 patients with chronic obstructive pulmonary disease (COPD) who were treated in our hospital from February 2014 to January 2016 and included them in the study group and the control group according to the voluntary principle. The study group was treated with tiotropium bromide(136310-93-5) dry powder inhalation, and the control group was treated with ipratropium bromide aerosol. After 4 weeks of continuous administration, the pulmonary function of the patients before and after the administration was observed.

The pulmonary function indexes of FVC, FEV1, FEV1%, PaO2, PaCO2 were all significantly better than those of the control group after 4 weeks of continuous treatment (P <0.05).

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved